VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BTIBritish American Tobacco p.l.c.
$60.89$131.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBTIFinancials

British American Tobacco p.l.c. (BTI) Income Statement

30Y historyFree accessUpdated daily

Revenue has been flat (TTM growth -1.0%), with gross margins resilient at 83.4% in 2025Q4 but operating margin compressing to 38.2% in 2026Q2 from 42.0% a year earlier, reflecting an 80% jump in SG&A to $2.7B.

Income StatementBalance SheetCash FlowRatios

BTI Income Statement

Annual statement

BTI Income Statement

British American Tobacco p.l.c. (BTI) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue51.46B25.61B25.87B27.28B27.66B25.68B25.78B25.88B24.49B19.56B14.13B12.54B13.97B15.26B15.19B15.4B14.88B14.21B12.12B10.02B9.76B9.32B10.77B25.62B24.68M11.37B10.91B9.07B7.12B7.15B7.24B
Revenue Growth %--0.99%-5.19%-1.35%7.67%-0.36%-0.39%5.65%25.19%38.46%12.72%-10.27%-8.45%0.46%-1.36%3.47%4.75%17.21%21%2.62%4.69%-13.4%-57.97%--99.78%4.18%20.32%27.42%-0.45%-1.23%6.94%
Cost of Goods Sold11.54B4.23B4.44B4.89B4.8B4.6B4.45B4.46B4.6B5.03B3.73B3.03B3.03B3.24B3.31B3.43B3.71B3.95B3.32B2.77B2.87B2.76B000000000
COGS % of Revenue-16.5%17.15%17.93%17.37%17.9%17.25%17.24%18.77%25.73%26.42%24.19%21.69%21.25%21.8%22.25%24.91%27.79%27.36%27.67%29.42%29.6%---------
Gross Profit39.92B21.38B21.43B22.39B22.85B21.09B21.33B21.42B19.89B14.53B10.4B9.5B10.94B12.02B11.88B11.97B11.18B10.26B8.81B7.25B6.89B6.57B10.77B25.62B24.68M11.37B10.91B9.07B7.12B7.15B7.24B
Gross Margin %-83.5%82.85%82.07%82.63%82.1%82.75%82.76%81.23%74.27%73.58%75.81%78.31%78.75%78.2%77.75%75.09%72.21%72.64%72.33%70.58%70.4%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %--0.22%-4.29%-2.01%8.37%-1.13%-0.41%7.65%36.91%39.76%9.41%-13.14%-8.95%1.17%-0.79%7.13%8.93%16.51%21.53%5.17%4.95%-39.03%-57.97%--99.78%4.18%20.32%27.42%-0.45%-1.23%6.94%
Operating Expenses26.73B11.39B18.56B38.14B12.33B10.85B11.37B11.8B9.98B16.01B3.58B3.15B5.66B5.76B6.47B10.42B10.2B10.01B5.38B4.42B4.26B4.22B8.38B22.92B22.12M8.76B8.36B7.16B5.53B5.31B5.62B
OpEx % of Revenue-44.46%71.76%139.81%44.58%42.26%44.1%45.6%40.74%81.84%25.3%25.16%40.48%37.73%42.57%67.69%68.51%70.45%44.34%44.09%43.65%45.23%77.87%89.44%89.64%77.02%76.56%78.88%77.64%74.2%77.54%
Selling, General & Admin9.44B1.12B3.95B3.86B3.83B3.81B3.76B2.87B3B2.61B2.1B1.95B2.07B2.36B15.1M0000000000000000
SG&A % of Revenue-4.38%15.27%14.13%13.85%14.83%14.59%11.11%12.25%13.35%14.9%15.57%14.8%15.48%0.1%----------------
Research & Development560M133M380M408M323M304M307M376M105M191M144M148M154M161M93M81M82M51M50M43M36M29M29M73M62M59M59M58M45M42M37M
R&D % of Revenue-0.52%1.47%1.5%1.17%1.18%1.19%1.45%0.43%0.98%1.02%1.18%1.1%1.05%0.61%0.53%0.55%0.36%0.41%0.43%0.37%0.31%0.27%0.28%251.2%0.52%0.54%0.64%0.63%0.59%0.51%
Other Operating Expenses2M10.13B14.23B33.88B8.18B6.74B7.3B8.55B79M136M170M-3.05B-3.68B-3.63B-3.6B-1.31B-1.23B-1.08B-954M-898M-888M-784M-252M292M-50K000000
Operating Income13.18B10B2.74B-15.75B10.52B10.23B9.96B10.41B10.03B7.17B5.26B4.93B5.04B5.78B5.41B4.72B4.32B4.1B3.57B2.9B2.62B2.42B3.76B1.85B2.18M2.18B1.78B1.48B1.01B1.3B1.71B
Operating Margin %-39.04%10.58%-57.73%38.05%39.85%38.65%40.24%40.96%36.64%37.2%39.36%36.05%37.88%35.63%30.66%29.01%28.86%29.47%28.99%26.86%25.95%34.92%7.23%8.83%19.14%16.34%16.3%14.2%18.22%23.67%
Operating Income Growth %-265.39%117.37%-249.68%2.82%2.73%-4.33%3.8%39.94%36.4%6.53%-2.03%-12.87%6.8%14.64%9.33%5.29%14.81%23%10.76%8.35%-35.64%103.02%84854.13%-99.9%21.97%20.62%46.29%-22.41%-23.98%4.13%
EBITDA17.28B12.27B5.84B8.25B11.6B11.18B10.82B11.36B11.07B7.98B5.81B5.34B5.46B6.17B5.89B5.54B5.21B4.71B4B3.24B2.98B2.8B4.13B2.73B340.18M2.57B2.19B1.83B1.31B1.54B1.95B
EBITDA Margin %-47.9%22.57%30.23%41.94%43.52%41.98%43.89%45.2%40.8%41.09%42.57%39.07%40.45%38.76%35.96%35.04%33.16%33.01%32.34%30.48%30.06%38.4%10.67%1378.25%22.62%20.02%20.16%18.37%21.56%26.86%
EBITDA Growth %-110.16%-29.24%-28.88%3.76%3.32%-4.74%2.61%38.7%37.47%8.8%-2.25%-11.57%4.86%6.3%6.19%10.67%17.74%23.52%8.91%6.14%-32.21%51.24%703.69%-86.77%17.71%19.46%39.83%-15.18%-20.72%4.18%
D&A (Non-Cash Add-back)4.1B2.27B3.1B24B1.08B944.87M858.02M945.48M1.04B812.31M549.75M402M423M393M475M817M897M611M430M336M353M383M375M882M338M396M401M350M297M239M231M
EBIT15.6B9.76B4.64B12.64B11.5B10.24B10.94B9.13B9.54B29.7B4.69B6.44B5.44B6.41B6.17B5.5B4.97B4.68B4.22B3.46B3.17B2.96B4B1.9B2.45B2.47B2.01B1.74B1.09B1.24B1.97B
Net Interest Income-2.71B-1.71B-1.1B-1.7B-1.59B-1.44B-1.74B-1.71B-1.58B-1.05B-607M-615M-523M-552M-499M-488M-525M-519M-404M-271M-292M-268M-256M-335M-333M-409M-489M-370M-355M-368M-340M
Interest Income422.02M214M0186M92M35M50M1.7B1.57B1.01B577M494M438M460M49M82M60M85M131M111M122M106M112M00000000
Interest Expense3.13B1.93B1.1B1.89B1.66B1.49B1.78B1.81B1.48B1.2B681M584M484M532M505M567M583M602M535M382M410M373M368M209M184K409M489M370M355M368M340M
Other Income/Expense-1.31B-138M802M-1.31B-1.2B-1.07B-1.29B-2.5B-1.68B22.36B989M921M-188M19M-456M-460M-708M-238M-424M-269M-302M-349M-130M-210M-67M-111M-262M-108M-273M-428M-88M
Pretax Income11.88B9.86B3.54B-17.06B9.32B9.16B8.67B7.91B8.35B29.53B6.25B5.86B4.85B5.8B5.65B4.93B4.39B4.08B3.68B3.08B2.76B2.58B3.63B1.57B2.11M2.06B1.52B1.37B738M875M1.63B
Pretax Margin %-38.5%13.68%-62.53%33.72%35.68%33.64%30.58%34.1%150.93%44.2%46.71%34.7%38%37.18%32.02%29.48%28.72%30.39%30.71%28.31%27.71%33.71%6.12%8.56%18.16%13.94%15.11%10.37%12.23%22.46%
Income Tax2.24B2.09B357M-2.87B2.48B2.19B2.11B2.06B2.14B-8.13B1.41B1.33B1.46B1.6B1.53B1.56B1.25B1.12B1.02B790M716M690M673M779M818K886M660M673M277M357M520M
Effective Tax Rate %18.86%21.24%10.09%16.83%26.58%23.89%24.31%26.07%25.64%-27.53%22.51%22.77%30.01%27.59%27.02%31.56%28.44%27.55%27.82%25.67%25.9%26.7%18.54%49.71%38.71%42.91%43.36%49.09%37.53%40.8%31.98%
Net Income9.55B7.76B3.07B-14.37B6.67B6.8B6.4B5.7B6.03B37.53B4.65B4.29B3.12B3.9B3.84B3.1B2.88B2.71B2.46B2.13B1.9B1.77B2.83B631M1.15M1.01B692M556M346M412M988M
Net Margin %-30.32%11.86%-52.66%24.1%26.48%24.83%22.04%24.63%191.85%32.89%34.22%22.3%25.58%25.29%20.1%19.34%19.09%20.27%21.26%19.42%18.95%26.25%2.46%4.67%8.88%6.34%6.13%4.86%5.76%13.64%
Net Income Growth %-153.06%121.35%-315.53%-1.98%6.27%12.2%-5.44%-83.93%707.51%8.34%37.72%-20.21%1.64%24.1%7.5%6.12%10.42%15.35%12.34%7.3%-37.5%348.02%54674.31%-99.89%45.95%24.46%60.69%-16.02%-58.3%14.88%
Net Income (Continuing)9.64B7.76B3.18B-14.19B6.85B6.97B6.56B5.35B5.79B37.66B2.61B3.29B2.67B3.46B4.08B3.38B3.14B2.96B2.66B2.29B2.05B1.89B2.96B788M1.29B1.18B862M698M461M518M1.11B
Discontinued Operations0000000000000000000000000000000
Minority Interest216M219M352M368M342M300M282M258M244M222M224M138M304M301M307M307M342M299M271M218M227M247M198M225M267K329M419M455M323M342M327M
EPS (Diluted)-3.491.36-6.472.922.962.792.492.6618.282.492.301.672.051.971.561.441.361.231.040.910.841.130.270.500.440.300.250.220.260.64
EPS Growth %-156.62%121.02%-321.58%-1.35%6.09%12.05%-6.39%-85.45%634.14%8.26%37.72%-18.54%4.06%26.28%8.33%5.88%10.57%18.27%14.29%8.33%-25.66%318.52%-46%13.64%46.67%20%13.64%-15.38%-59.38%14.29%
EPS (Basic)-3.511.37-6.492.932.972.802.502.6818.342.502.311.672.051.981.571.451.371.231.050.920.841.130.270.510.440.300.250.220.270.64
Diluted Shares Outstanding2.18B2.2B2.23B2.23B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B2.26B
Basic Shares Outstanding2.17B2.19B2.21B2.22B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B2.25B
Dividend Payout Ratio-65.99%169.92%-73.73%72.11%74.14%80.61%72.07%9.23%62.61%64.57%87.06%66.88%66.08%76.19%72.7%66.27%56.7%56.24%53.16%51.5%30.28%122.5%61.37%------

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetStrained
Cash FlowStable
Top Statement Risk

US regulatory and volume decline

Top-Line Stagnation Amid Portfolio Shift

Revenue has been essentially flat over the past two years, with TTM growth at -1.0%, as combustible volume declines offset gains in New Categories, according to recent financial statements.

The most recent quarter (2026Q2) shows a 2.1% YoY revenue increase, but this follows a -2.2% decline in 2025Q2, indicating a volatile and overall decelerating trend. The lack of consistent growth suggests that the company's transformation is not yet generating sufficient top-line momentum to offset legacy declines. Investors should monitor whether New Category revenue can accelerate to a level that drives sustainable growth.

Gross Margin Resilience, Operating Pressure

Gross margin remains robust at 83.5% in 2025Q4, but operating margin has compressed to 38.2% in 2026Q2 from 42.0% a year earlier, as reported in quarterly filings.

The stability of gross margin indicates strong pricing power and a cost structure dominated by excise taxes rather than production costs. However, the operating margin decline suggests increased SG&A or promotional spending, likely in New Categories. This margin compression may persist as the company invests to gain share in vapor and heated tobacco, potentially pressuring near-term profitability.

Operating Leverage Fading as Costs Rise

Operating income has not scaled with revenue; in 2026Q2, operating income of $4.7B is below the $5.1B reported in 2025Q2, despite similar revenue levels, based on income statement data.

The data reveals that SG&A expenses increased from $1.5B in 2025Q2 to $2.7B in 2026Q2, a significant jump that has eroded operating leverage. This suggests that the company is spending more on marketing and distribution to defend market share, which may be necessary but dilutes incremental profitability. If this trend continues, operating margins could face further pressure.

Impairments Distort Earnings History

Net income swung from a -$18.3B loss in 2023Q4 to a $3.2B profit in 2026Q2, driven by a $31.5B non-cash impairment in 2023, as disclosed in financial reports.

The massive impairment in 2023Q4 reflects a write-down of US combustible brand values, which is a non-cash charge that obscures underlying profitability. Excluding this, earnings have been relatively stable, but the impairment signals a shorter economic life for legacy brands. Investors should adjust for such one-time items to assess true earning power, and monitor for any further impairments.

SG&A Spike Threatens Margin Stability

SG&A expenses jumped to $2.7B in 2026Q2 from $1.5B in 2025Q2, a 80% increase, while COGS remained flat, according to quarterly income statement data.

The sharp rise in SG&A is the primary driver of operating margin compression, suggesting increased investment in marketing and distribution, likely for New Categories. This may be a deliberate strategy to build market share, but it raises questions about cost discipline. If SG&A remains elevated without corresponding revenue growth, profitability will continue to suffer.

Balance Sheet Strain and Regulatory Overhang

With a current ratio of 0.87 and an Altman Z-Score of 1.46, BTI's liquidity and solvency metrics appear strained, as per recent risk assessments.

The weak liquidity ratios and distress-zone Z-Score suggest that the company may face challenges in meeting short-term obligations without external financing. This, combined with the risk of US menthol bans and FDA enforcement, could pressure the stock. Short-sellers might argue that the company's high dividend is unsustainable given the need for investment and potential regulatory shocks.

BTI — Frequently Asked Questions

Quick answers to the most common questions about buying BTI stock.

What was British American Tobacco p.l.c.'s (BTI) revenue in 2025?

For fiscal year 2025, British American Tobacco p.l.c. (BTI) reported total revenue of $25.61B. This represents a 253.7% increase compared to $7.24B in 1996.

Is British American Tobacco p.l.c. (BTI) profitable?

British American Tobacco p.l.c. (BTI) is profitable, generating $7.76B in net income for the fiscal year ending 2025 with a net profit margin of 30.3%.

What is British American Tobacco p.l.c.'s operating profit margin?

British American Tobacco p.l.c. (BTI) reported an operating income of $10.00B, resulting in an operating profit margin of 39.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is British American Tobacco p.l.c.'s gross profit and gross margin?

British American Tobacco p.l.c. (BTI) generated $21.38B in gross profit for the year, representing a gross profit margin of 83.5%. This demonstrates the company's core pricing power and production efficiency.